| Dataset | DrugBank Drug Targets |
| Category | physical interactions |
| Type | drug |
| Description | A pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment. (Chemical Entities of Biological Interest Ontology, CHEBI_75998) |
| External Link | http://www.drugbank.ca/drugs/DB08911 |
| Similar Terms | |
| Downloads & Tools |
2 interacting proteins for the Trametinib drug from the curated DrugBank Drug Targets dataset.
